Investigating the effect of tranexamic acid drug on bleeding and surgical outcomes of myoma removal through hysteroscope

Phase 3

Recruiting

• Conditions: terus myoma.; Leiomyoma of uterus, unspecified; D25.9

• Registration Number: IRCT20230316057738N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Have a single myoma
Grade 0, 1, and 2 myomas
Myomas smaller than 4 cm

Exclusion Criteria

Have intracranial bleeding
Have any sensitivity to the drug tranexamic acid
Have thromboembolic and ischemic heart diseases
There are uterine abnormalities
Have an active pelvic infection
Have a history of hemorrhagic disease
Pregnancy
Previous hystreroscopy surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Better vision during surgery. Timepoint: During surgery. Method of measurement: Surgeon rating.;Bleeding during surgery. Timepoint: During surgery. Method of measurement: Surgeon rating.;Duration of operation. Timepoint: From the beginning of surgery to the end of surgery. Method of measurement: Minutes.;Hemoglobin reduction rate. Timepoint: Before the operation and 24 hours after the operation. Method of measurement: Milligram on deciliter.;Complications of the operation. Timepoint: During or after surgery. Method of measurement: Patient symptoms.;The completeness of the operation in one step. Timepoint: One month after surgery. Method of measurement: Sonography.